Form 4: Neogenomics COO Reports Stock Transaction
Insider Transaction (Form 4)
Warren Stone, Pres & Chief Operating Officer of Neogenomics Inc, reported multiple transactions in common stock on August 21, 2026.
Summary
- Option exercise/conversion: acquired 28,106 Common Stock on August 21, 2026; holds 192,138 after (Direct).
- Tax/exercise-price withholding: disposed of 11,060 Common Stock on August 21, 2026; holds 181,078 after (Direct).
- Option exercise/conversion: disposed of 28,106 Restricted Stock Unit on August 21, 2026; holds 28,106 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Warren Stone — Officer (Pres & Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Option exercise/conversion | Common Stock | 28,106 | — | — | 192,138 |
| 2026-08-21 | Tax/exercise-price withholding | Common Stock | 11,060 | — | — | 181,078 |
| 2026-08-21 | Option exercise/conversion | Restricted Stock Unit | 28,106 | — | — | 28,106 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Option exercise/conversion (28,106 shares) |
| 2026-08-21 | Tax/exercise-price withholding (11,060 shares) |
| 2026-08-21 | Option exercise/conversion (28,106 shares) |
Keywords
insider transaction, Form 4, NEO, NEOGENOMICS INC, neutral, Warren Stone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.